Daniel P. Alford, MD, MPH is Professor of Medicine, Assistant Dean of Continuing Medical Education and Director of the Safe and Competent Opioid Prescribing Education (SCOPE of Pain) program at Boston University School of Medicine (BUSM). He is on staff in the Section of General Internal Medicine and director of the Clinical Addiction Research and Education (CARE) Unit at Boston Medical Center (BMC). He is also Medical Director of the Office-Based Opioid Treatment (OBOT) program, the Boston University Evidence-based SBIRT Student Training (BESST) Project and the Massachusetts SBIRT Training and Technical Assistance (MASBIRT TTA) program. He is immediate past-president of the Association for Medical Education and Research in Substance Abuse (AMERSA). He was recognized as a Champion of Change by the White House. In 2014 he received the American Medical Association “Award for Health Education” and in 2016 was awarded the first Educator of the Year Award by the American Society of Addiction Medicine (ASAM) and the Award for Distinguished Contributions to Behavioral Medicine by the American College of Physicians (ACP). His clinical, educational and research interests focus on opioid use disorders and safe and competent opioid prescribing for chronic pain.
- Assistant Dean, Continuing Medical Education, Boston University School of Medicine
- Active Staff Hospital Privileges, Medicine, Boston Medical Center
- Safe and Competent Opioid Prescribing Education (SCOPE of Pain) Program
- Boston University School of Medicine CME office
- Immersion Training Program in Addiction Medicine
- Department of Medicine Faculty
- Boston Medical Center Physician Provider Profile
- Association for Medical Education and Research in Substance Abuse (AMERSA)
- Boston University, MD
- Boston University, MPH
- Connecticut College, BA
- Marietta College, BA
- Published on 9/1/2017
Liebschutz JM, Xuan Z, Shanahan CW, LaRochelle M, Keosaian J, Beers D, Guara G, O'Connor K, Alford DP, Parker V, Weiss RD, Samet JH, Crosson J, Cushman PA, Lasser KE. Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Clinical Trial. JAMA Intern Med. 2017 Sep 01; 177(9):1265-1272. PMID: 28715535.
- Published on 4/4/2017
Alford DP, Cohen ML, Reynolds EE. How Would You Manage Opioid Use in These Three Patients?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Ann Intern Med. 2017 Apr 04; 166(7):506-513. PMID: 28384742.
- Published on 4/1/2017
Levy S, Seale JP, Osborne VA, Kraemer KL, Alford DP, Baxter J, Finnell DS, Kunins H, Walley AY, Lewis DC, MacLane-Baeder D, Gordon AJ. The Surgeon General's Facing Addiction report: An historic document for health care. Subst Abus. 2017 Apr-Jun; 38(2):122. PMID: 28328384.
- Published on 7/1/2016
Alford DP, Carney BL, Brett B, Parish SJ, Jackson AH. Improving Residents' Safe Opioid Prescribing for Chronic Pain Using an Objective Structured Clinical Examination. J Grad Med Educ. 2016 Jul; 8(3):390-7. PMID: 27413443.
- Published on 6/27/2016
Tsui JI, Lira MC, Cheng DM, Winter MR, Alford DP, Liebschutz JM, Edwards RR, Samet JH. Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy. Drug Alcohol Depend. 2016 Sep 01; 166:26-31. PMID: 27422763.
- Published on 1/28/2016
Alford DP. Opioid Prescribing for Chronic Pain--Achieving the Right Balance through Education. N Engl J Med. 2016 Jan 28; 374(4):301-3. PMID: 26816007.
- Published on 1/25/2016
Alford DP, German JS, Samet JH, Cheng DM, Lloyd-Travaglini CA, Saitz R. Primary Care Patients with Drug Use Report Chronic Pain and Self-Medicate with Alcohol and Other Drugs. J Gen Intern Med. 2016 May; 31(5):486-91. PMID: 26809204.
- Published on 1/1/2016
Alford DP, Zisblatt L, Ng P, Hayes SM, Peloquin S, Hardesty I, White JL. SCOPE of Pain: An Evaluation of an Opioid Risk Evaluation and Mitigation Strategy Continuing Education Program. Pain Med. 2016 Jan; 17(1):52-63. PMID: 26304703.
- Published on 10/9/2015
Fuster D, Cheng DM, Wang N, Bernstein JA, Palfai TP, Alford DP, Samet JH, Saitz R. Brief intervention for daily marijuana users identified by screening in primary care: A subgroup analysis of the ASPIRE randomized clinical trial. Subst Abus. 2016 Apr-Jun; 37(2):336-42. PMID: 26453188.
- Published on 5/22/2015
Tsui JI, Lira MC, Cheng DM, Winter MR, Alford DP, Liebschutz JM, Mao J, Edwards RR, Samet JH. Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders. Drug Alcohol Depend. 2015 Aug 1; 153:286-92. PMID: 26048638.
View 46 more publications: View full profile at BUMC